Hologic Announces Financial Results for First Quarter of Fiscal 2016

Go back to Hologic Announces Financial Results for First Quarter of Fiscal 2016

Leerink Partners Remains Bullish on Hologic (HOLX) as Lower Tax Rate Helps Drive 1Q Results

January 28, 2016 9:31 AM EST

Leerink Partners maintained an Outperform rating on Hologic (NASDAQ: HOLX), and cut the price target to $44.00 (from $47.00), following the company's 1Q earnings report. HOLX reported revenue of $695M, which was $6M ahead of the Street's estimate, with outperformance primarily from GYN and... More

Needham & Company Upgrades Hologic (HOLX) to Buy

January 28, 2016 7:30 AM EST

Needham & Company upgraded Hologic (NASDAQ: HOLX) from Hold to Buy with a price target of $41.00.

Analyst Mike Matson commented, "HOLX's F1Q16 revenue and EPS beat consensus. Management lowered its FY16 revenue guidance due to currency but raised its EPS... More

Hologic (HOLX) Tops Q1 EPS by 4c; Guides FY EPS Higher

January 27, 2016 4:07 PM EST

Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $695.2 million versus the consensus estimate of $688.04 million.

GUIDANCE:

Hologic sees Q2 2016 EPS of $0.45-$0.46, versus the consensus of $0.45. Hologic sees Q2... More